Abiopharma

🔍 O'Sullivan Colleen M (Executive)

Company: ZEBRA TECHNOLOGIES CORP (ZBRA)

Report Date: 2026-05-02

Detailed Transactions and Holdings:

• Sold 87 shares of Class A Common Stock at $227.08 per share (Direct)
  Date: 2026-05-02 | Code: F | equity_swap_involved: 0 | shares_owned_after: 7,834.00 | transaction_form_type: 4
• Sold 334 shares of Class A Common Stock at $223.73 per share (Direct)
  Date: 2026-05-04 | Code: F | equity_swap_involved: 0 | shares_owned_after: 7,500.00 | transaction_form_type: 4
• Holds 0 shares of Class A Common Stock (Direct)
  Date: 2026-05-02 | Code: H | shares_owned_after: 7,921.00
• Holds 658 shares of Stock Appreciation Right at $244.97 per share (Derivative)
  Date: 2026-05-02 | Code: H | Expires: 2027-04-30 | shares_owned_after: 658.00 | Footnotes: F1

Footnotes:

• F1: These stock appreciation rights became exercisable in four equal annual installments beginning on April 30, 2021.